Dr. Fonseca shares the current landscape regarding the research being conducted in cancer therapeutics. He reviews steps being taken to better address this serious human problem. He proposes that the pace of research is such that in the next few decades we will see a dramatic improvement in our ability to treat patients with these conditions, and ultimately most patients will be cured when diagnosed in the future. Rafael Fonseca, MD, is the Getz Family Professor of cancer and a Professor of Medicine. He is a consultant in the Division of Hematology/Oncology at the Mayo Clinic, AZ and Chair of the Department of Medicine. Dr Fonseca earned his MD at Universidad Anahuac, Mexico. He completed a residency in internal medicine at the University of Miami, FL, and a fellowship in hematology and medical oncology at Mayo Graduate School of Medicine, Rochester, MN. He is a clinical investigator for the Damon Runyon Cancer Research Fund.
Dr Fonseca’s practice has focused on the diagnosis and treatment of plasma cell disorders and leading the multiple myeloma team in its effort to develop a better understanding of the disease and its impact on patients. In his laboratory, Dr Fonseca has led his team of researchers in concentrating on the genetic nature of the clonal cells of plasma cell disorders. He is also interested in myeloma bone disease, prognostic markers and development of new therapies for the disease.
Throughout his training and career, Dr Fonseca has received numerous awards and honors, including the Young Investigator Award in Hematology (Celgene – Achievement Awards for Clinical Research in Hematology), Damon Runyon-Walter Winchell Clinical Investigator Award, and the International Waldenström Macroglobulinemia Research Award. Most notably he is a Mayo Clinic Distinguished Investigator, the highest academic distinction given to investigators at his institution. Dr. Fonseca holds memberships and serves in positions for organizations such as the American Society of Clinical Oncology, American Society of Hematology, American Association for Cancer Research, and the
International Myeloma Society. Dr Fonseca has an adjunct academic appointment at the Translational Genomics Research Institute (TGen). His research has been funded by the National Cancer Institute (R01, P01, SPORE), the Leukemia and Lymphoma Society, the Multiple Myeloma Research Fund, and the Damon Runyon Cancer Research Fund.
Dr Fonseca serves as reviewer and in editorial capacities for medical publications including Blood, Lancet, Nature Medicine, Cancer Cell, Leukemia, and the New England Journal of Medicine, among others. He is a frequent reviewer of grants and sits on the SPORE grant review panel. He has given many national and international presentations as a visiting professor, and has authored numerous articles (over 200), book chapters, editorials, abstracts, and letters. This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx
May is Skin Cancer Awareness Month, and Lisa Pace is…
A pioneering treatment centre for cancer patients has…
Results of a study on breast cancer are expected to change…
Let us help fight cancer. Share your knowledge.
Latest news, views, insights and trends on cancer treatment, discovery and support